Enhanced antithrombotic effects with the combination of rivaroxaban - a novel, oral, direct factor Xa inhibitor and clopiclogrel, in animal models

被引：0
|
作者：
Perzborn, E. [1 ]
Fischer, E. [1 ]
Lange, U. [1 ]
机构：
[1] Bayer HealthCare, Pharma R&D Discovery Res, Wuppertal, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 141卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
220
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [1] Rivaroxaban, a novel, oral, direct Factor Xa inhibitor, enhanced the antithrombotic effects of clopidogrel and acetylsalicylic acid in rats
    Perzborn, E.
    Fischer, E.
    Lange, U.
    EUROPEAN HEART JOURNAL, 2007, 28 : 189 - 189
  • [2] Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
    Abrams, Paris J.
    Emerson, Christopher R.
    PHARMACOTHERAPY, 2009, 29 (02): : 167 - 181
  • [3] Antithrombotic effects enhanced with the combination of rivaroxaban, clopiclogrel and acetylsalicylic acid in rats
    Perzborn, E.
    Fischer, E.
    Lange, U.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 81 - 81
  • [4] Effects of rivaroxaban, a novel, oral, direct Factor Xa inhibitor, on coagulation assays
    Samama, M. M.
    Fem, L. L.
    Guinet, C.
    Perzborn, E.
    Martinoli, J.
    Depasse, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 693 - 693
  • [5] Effects of rivaroxaban, a novel, oral, direct factor Xa inhibitor, on coagulation assays
    Samama, M. M.
    Le Flem, L.
    Guinet, C.
    Perzborn, E.
    Martinoli, J-L
    Depasse, F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 35 - 36
  • [6] Effects of the Novel, Oral, Direct Factor Xa Inhibitor Rivaroxaban on Coagulation Assays
    Samama, Meyer Michel
    Le Flem, Lena
    Guinet, Celine
    Perzborn, Elisabeth
    Martinoli, Jean-Luc
    Depasse, Francois
    BLOOD, 2008, 112 (11) : 1041 - 1042
  • [7] Rivaroxaban: An oral direct inhibitor of factor Xa
    Gulseth, Michael P.
    Michaud, Jessica
    Nutescu, Edith A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1520 - 1529
  • [8] Rivaroxaban, an oral direct factor Xa inhibitor
    Piccini, Jonathan P.
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (06) : 925 - 937
  • [9] Antithrombotic effects of rivaroxaban - an oral, direct Factor Xa inhibitor - in animal models of arterial and venous thrombosis: comparison with enoxaparin, an antithrombin-dependent anticoagulant
    Perzborn, E.
    Arndt, B.
    Fischer, E.
    Harwardt, M.
    Lange, U.
    Trabandt, A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 762 - 762
  • [10] Rivaroxaban, the first oral, direct factor Xa inhibitor
    Fassiadis, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 2945 - 2946
12345